IHS Chemical Week

People & Business :: Earnings/Finance

Lanxess expects large losses, announces fourth-quarter impairment charges

11:55 AM MST | February 26, 2014 | Natasha Alperowicz

Lanxess said today that it expects to record a net loss of €204 million ($280.2 million) for the fourth quarter of 2013 compared with a net income of €50 million in the year-earlier quarter, according to preliminary and unaudited numbers. The company expects a 5.1% reduction in fourth-quarter sales, to €2.01 billion. Ebitda pre-exceptionals is down 26.4%, to €176 million, with Ebitda margin down to 8.7% compared with 11.3% in the fourth quarter of 2012.   Full-year 2013 net loss is expected to total €159 million compared with a net...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa